ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,138.31
0.02%
Dow Jones
43,325.80
0.07%
Gold vs US Dollar
2,625.885
-0.26%
Brent Oil
73.325
0.60%
Bitcoin
96,252.05
0.59%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) News

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIAF
DateTimeSourceHeadlineSymbolCompany
17/12/202413:00Business WireJoin bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19NASDAQ:BIAFbioAffinity Technologies Inc
12/12/202413:00Business WirebioAffinity Technologies Set for Continued Expansion in 2025NASDAQ:BIAFbioAffinity Technologies Inc
05/12/202413:00Business WireVeterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply ScheduleNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202413:00Business WirebioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024NASDAQ:BIAFbioAffinity Technologies Inc
04/11/202413:00Business WirebioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product DevelopmentNASDAQ:BIAFbioAffinity Technologies Inc
30/10/202412:00Business WirebioAffinity Technologies Announces Award of Japanese Patent for CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
21/10/202415:39PR Newswire (US)WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
21/10/202414:45Business WirebioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
18/10/202418:57PR Newswire (US)WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
18/10/202416:45Business WirebioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
16/10/202412:00Business WirebioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry GuidelinesNASDAQ:BIAFbioAffinity Technologies Inc
10/10/202412:00Business WirebioAffinity Technologies Names J. Michael Edwards as Chief Financial OfficerNASDAQ:BIAFbioAffinity Technologies Inc
09/10/202412:00Business WirebioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung TestNASDAQ:BIAFbioAffinity Technologies Inc
18/09/202412:00Business WirePeer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and OverdiagnosisNASDAQ:BIAFbioAffinity Technologies Inc
26/08/202412:58IH Market NewsIBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without AstronautsNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202421:17Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202421:15Business WirebioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFONASDAQ:BIAFbioAffinity Technologies Inc
14/08/202420:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFbioAffinity Technologies Inc
14/08/202420:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFbioAffinity Technologies Inc
14/08/202413:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFbioAffinity Technologies Inc
14/08/202413:25Business WirebioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung SalesNASDAQ:BIAFbioAffinity Technologies Inc
12/08/202420:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIAFbioAffinity Technologies Inc
12/08/202420:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202418:00PR Newswire (US)WallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202417:17Business WirebioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202413:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202413:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
02/08/202414:00PR Newswire (US)WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
02/08/202413:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAF

Your Recent History

LSE
SYME
Supply@me Capital
LSE
GDR
Genedrive
LSE
BARC
Barclays
LSE
ZEN
Zenith Energy
LSE
TRP
Tower Resources
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
SCLP
Scancell
LSE
SRSP
Sirius Petroleum
LSE
CPX
Cap-xx
LSE
UPS
LSE
LLOY
Lloyds Banking
LSE
BIRD
Blackbird
LSE
VTY
Vistry
LSE
SEE
Seeing Machines
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads